CLDN18.2 Positive Solid Tumors Clinical Trials in Hefei, Anhui

An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell Injection in Subjects With CLDN18.2-Positive Advanced Malignant Solid Tumors